Tuesday, April 7, 2015 | 8:30 AM - 5:00 PM
Keynote Speaker: James W. Mier (Beth Israel Deaconess Medical Center/ Harvard Medical School, Boston, MA)
Speakers: Renier J. Brentjens (Memorial Sloan Kettering Cancer Center), Stephen D. Gillies (Provenance Biopharmaceuticals, Carlisle, MA), Jerome Ritz (Harvard Medical School), Gilles Uzé (Université Montpellier II, Montpellier, France), K. Dane Wittrup (Massachusetts Institute of Technology, Cambridge, MA)
Systemic toxicity currently prevents exploiting the potential of many cytokines to treat cancer, viral infections, inflammatory and autoimmune conditions. Targeted delivery of immune-stimulatory or immune-regulatory cytokines offers much promise.
Monday, May 18, 2015 | 12:00 PM - 4:00 PM
Keynote Speaker: Scott J. Miller (Yale University)
The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. The year-end meeting features keynote speaker Scott J. Miller of Yale University and a poster session.
Thursday, May 21, 2015 | 9:00 AM - 5:00 PM
Speakers: Rolf Brekken (University of Texas, Southwestern), Stephen J. Forman (City of Hope), Thomas F. Gajewski (The University of Chicago Medicine), Carl June (University of Pennsylvania), David Kaufman (Merck Research Laboratories), Mark R. Litzow (Mayo Clinic), Andy Minn (University of Pennsylvania), Elaine Pinheiro (Merck Research Laboratories), Robert Vonderheide (University of Pennsylvania)
This symposium will bring together leading experts in immunotherapy and immunology to discuss these emerging approaches, along with the challenges and opportunities faced in this evolving field.
Tuesday, May 26, 2015 | 8:30 AM - 4:30 PM
Speakers: Richard Allen (Pfizer), John Burke (Applied BioMath), Nitin Mehrotra (US Food and Drug Administration), Tim Rolph (Pfizer), Vikram Sinha (US Food and Drug Administration), Peter Sorger (Harvard Medical School), Paul Watkins (Hamner-UNC Institute for Drug Safety Sciences)
Quantitative Systems Pharmacology (QSP) has been used successfully in drug discovery and development, yet lacks industry-wide adoption. This symposium highlights past successes and future challenges of using QSP in preclinical and clinical research.
Thursday, May 28, 2015 | 8:00 AM - 3:00 PM
Keynote Speaker: Craig Thompson (Memorial Sloan-Kettering Cancer Center)
Speakers: John Blenis (Weill Cornell Medical College ), Lydia Finley (Memorial Sloan-Kettering Cancer Center), Alec Kimmelman (Harvard Medical School), Christian M. Metallo (University of California, San Diego ), Elena Piskounova (University of Texas, Southwestern ), Sohail Tavazoie (The Rockefeller University )
This symposium will highlight insights into tumor metabolism from leaders in the field and explore how this information is being used to design safe and effective, metabolism-targeted therapies.
Tuesday, March 24, 2015 | 11:45 AM - 4:00 PM
Speakers: P. Jeffrey Conn (Vanderbilt University), Ron Dror (Stanford University), Christopher Fotsch (Amgen), Corey Hopkins (Vanderbilt University), Whitney Nolte (Pfizer)
In this symposium, academic and industry scientists will describe the identification, characterization, and development of PAMs for challenging GPCRs.
Tuesday, February 24, 2015 | 8:30 AM - 4:30 PM
Speakers: Chad Cowan (Harvard University), James Inglese (National Center for Advancing Translational Sciences, NIH), J. Keith Joung (Massachusetts General Hospital), Randall Platt (Massachusetts Institute of Technology), Yi Yang (Novartis Institutes for Biomedical Research), Lei (Stanley) Qi (University of California San Francisco)
The emergence of genome editing technologies such as TALEN and CRISPR/Cas9 are revolutionizing our ability to rapidly engineer mammalian systems. This symposium explores the frontiers of genome editing and potential to aid therapeutic development.
Thursday, January 29, 2015 | 6:30 PM - 8:00 PM
Speakers: Susan D. Croll (Associate Director, Pain, Addiction & Neurology Postdoctoral Program Director Regeneron Pharmaceuticals), Uzi de Haan (Director of Entrepreneur Postdoc Program at Cornell Tech), Karen Hanson Widbin (Manager of Postdoctoral Program Operations)
Join the Science Alliance (NYAS) as we discuss the non-traditional postdoc's alternatives. Topics will include differences between academia and industry, hiring and transition mechanisms, salaries and challenges.
Wednesday, January 21, 2015 | 8:30 AM - 4:00 PM
Speakers: Jasna Brujic (New York University), Bridget Carragher, John Chodera, Oliver Clarke, Erik Debler, Nancy Greenbaum, David Hall, Barry Honig, Jinrang Kim (Columbia University), Nina Liu (Albert Einstein College of Medicine), Patrick Loria (Yale University), Sean McSweeney (Brookhaven National Lab), Clint Potter
The New York Area Structural Biology Discussion Group convenes twice annually and presents talks and poster sessions from graduate students, postdocs, and laboratory heads.
Speakers: Susan D. Croll (Regeneron), Uzi de Haan (Cornell Tech), and Karen Hanson Widbin (Pfizer)
This eBriefing looks at nontraditional postdoctoral tracks in drug discovery and applied research.
Organizers: Peng Wu (Albert Einstein College of Medicine) and Jennifer Henry (formerly at The New York Academy of Sciences)
Keynote Speakers: Jim Paulson (Scripps Research Institute) and K. Barry Sharpless (Scripps Research Institute)
This eBriefing explores recent developments in the search for click reactions with applications in disease diagnosis and therapy.
Edited by Annals of the New York Academy of Sciences
This Annals volume presents scientific achievements by winners and finalists of the 2013 Prix Galien USA, honoring excellence in pharmaceutical science.
Organizers: John A. Allen (Pfizer), Mercedes Beyna (Pfizer), Bryan L. Roth (University of North Carolina School of Medicine), and Jennifer Henry (formerly at The New York Academy of Sciences)
This eBriefing looks at how to exploit biased ligand signaling at GPCRs to improve therapeutics for cardiovascular and CNS disorders.
Delve into the world of prebiotic and probiotic science. We talk to three people in the field and learn why keeping the good microbes in our bodies happy means a lot for health.
December 18, 2009
We sit down with science photographer Felice Frankel and nanotechnology pioneer and Harvard chemist George Whitesides to hear about their new book on nanoscience, No Small Matter.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.